Numerous investigations have been conducted using molecular profiling to evaluate the possible clonal origin of second malignancies in various cancer types. However, to date no study assessing clonality of multiple primaries has been conducted in melanoma. In this investigation using patients treated at a specialist melanoma treatment center, we compared the somatic mutational profiles of pairs of melanomas designated as independent on the basis of thorough assessment of their clinical and pathologic characteristics. We used a set of highly polymorphic genetic markers selected on the basis of their chromosomal positions and the frequencies of reported allelic losses at these genetic loci. Our statistical testing strategy showed no significa...
<div><p>To reveal the clonal architecture of melanoma and associated driver mutations, whole genome ...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
This study aimed to determine the frequency and concordance of BRAF and NRAS mutation in tumours ari...
Numerous investigations have been conducted using molecular profiling to evaluate the possible clona...
Numerous investigations have been conducted using molecular profiling to evaluate the possible clona...
Abstract Background: Alterations in key-regulator genes of disease pathogenesis (BRAF, cKIT, Cyclin...
Background: Melanoma has a complex molecular background and multiple genes are involved in its devel...
It is well known that synchronous and/or metachronous multiple primary melanomas (MPMs) occur in cle...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
“Cutaneous melanoma is a most unpredictable lesion” wrote Alexander Breslow in 1970. He was one of t...
It is well known that synchronous and/or metachronous multiple primary melanomas (MPMs) occur in cle...
Background: Multiple primary melanomas (MPMs) could represent an interesting field of investigation ...
Diversity between metastatic melanoma tumours in individual patients is known; however, the molecula...
<div><p>Background</p><p>While a number of autosomal dominant and autosomal recessive cancer syndrom...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
<div><p>To reveal the clonal architecture of melanoma and associated driver mutations, whole genome ...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
This study aimed to determine the frequency and concordance of BRAF and NRAS mutation in tumours ari...
Numerous investigations have been conducted using molecular profiling to evaluate the possible clona...
Numerous investigations have been conducted using molecular profiling to evaluate the possible clona...
Abstract Background: Alterations in key-regulator genes of disease pathogenesis (BRAF, cKIT, Cyclin...
Background: Melanoma has a complex molecular background and multiple genes are involved in its devel...
It is well known that synchronous and/or metachronous multiple primary melanomas (MPMs) occur in cle...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
“Cutaneous melanoma is a most unpredictable lesion” wrote Alexander Breslow in 1970. He was one of t...
It is well known that synchronous and/or metachronous multiple primary melanomas (MPMs) occur in cle...
Background: Multiple primary melanomas (MPMs) could represent an interesting field of investigation ...
Diversity between metastatic melanoma tumours in individual patients is known; however, the molecula...
<div><p>Background</p><p>While a number of autosomal dominant and autosomal recessive cancer syndrom...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
<div><p>To reveal the clonal architecture of melanoma and associated driver mutations, whole genome ...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
This study aimed to determine the frequency and concordance of BRAF and NRAS mutation in tumours ari...